Introduction
Calcium (Ca2+) is an essential signalling molecule is known about the VGCC with reference to these diseases and to speculate on the implications for in many biological systems, and normal intracellular other human diseases. calcium levels at~100 nM are 20 000-fold lower than the 2 mM concentration found extracellularly. Homoeostatic mechanisms are tightly controlled to enable Ca2+ to mediate a variety of cellular functions VGCC structure and function and to prevent sustained rises in intracellular calcium concentration which result in cell death.
VGCCs are transmembrane proteins that open in Abnormalities of calcium homoeostasis are recogresponse to membrane depolarization and allow nized to play an important role in the excitotoxic Ca2+ ions to enter the cell from the extracellular damage which occurs in the setting of cerebrovascuspace. VGCCs are hetero-oligomeric proteins, comlar disease and various neurodegenerative diseases. 1 prising an a 1 subunit which forms the channel pore More recently, however, abnormalities of the voltageand voltage sensor as well as accessory b, c and gated calcium channel (VGCC), one of the key a 2 d subunits. Until recently it was thought that an regulators of intracellular calcium concentration, accessory c-subunit was only present in skeletal have been implicated in a wide range of human muscle, but the existence of a neuronal c-subunit, diseases, including migraine,2 episodic ataxia,2 spinowhich associates with the a 1B -subunit to form an cerebellar degeneration,3 the Lambert-Eaton N-type VGCC, is now recognized.14 These accessory myasthenic syndrome,4 hypokalaemic periodic parasubunits influence the voltage-dependence and kinetlysis5 and X-linked congenital stationary night blindics of the a 1 subunit. The a 1 subunit comprises four ness (xlCSNB).6,7 It has been suggested that domains (I-IV), each of which has six transmemamyotrophic lateral sclerosis may be mediated by brane-spanning helices (S1-S6). The fourth helix (S4) antibodies directed against the VGCC,8 but the of each domain is highly charged and acts as a weight of evidence does not support this hypothesis. 9 voltage sensor. The extracellular loop between the Of further interest is the implication of the voltagefifth (S5) and sixth (S6) helices dips into the memgated calcium channel in spontaneous mouse models brane, and contributes to the channel pore ( Figure 2 ). of epilepsy10-12 and the muscular dysgenesis mouse. 13 The whole structure is envisaged to fold around, Recently there have been many advances in the with the amino and carboxy termini meeting, to form understanding of the molecular biology of the VGCC, a barrel-like structure.15,16 The b-subunits lack aand of the immunological and genetic basis for the helices capable of spanning the membrane, sugdisorders mentioned above, but our understanding gesting that they are entirely intracellular in location. of how such a diverse array of diseases may result
The a 2 and d subunits are encoded by a single gene from dysfunction of a single ion channel remains and then processed to form two disulphide-linked polypeptides. The d-subunit traverses the plasma incomplete. In this article, I hope to summarize what the various a 1 subunits to form functionally distinct channels. Further channel diversity is generated by VGCCs have been characterized genetically and pharmacologically (functionally), but these two alternative splicing. Dihydropyridine-sensitive L-type VGCCs are a approaches do not easily converge to yield a single coherent classification. Nine a 1 (Table 1) , one a 2 d, group of high-voltage-activated calcium channels in Figure 2 . Membrane topology of the pore-forming a 1 subunit of the voltage-gated calcium channel. It comprises four domains (I-IV), each of which is made up of six transmembrane regions. The fourth transmembrane region (S4) is highly charged and serves as a voltage-sensor. The region between S5 and S6 of each domain dips into the plasma membrane and contributes to the channel pore. The b subunit interacts with the a 1 subunit via the cytoplasmic loop between domains I and II (Loop I-II ). The cytoplasmic loop between domains II and III is important for excitation-contraction coupling in skeletal muscle and for excitation-secretion coupling in neurons. The locations of mutations in human diseases and mouse models are indicated. (Table 2 ). These mutations from the SR to the cytosol leads to muscle contraction. In contrast, Ca2+ entry via the P/Q-type VGCC lead to enhanced Ca2+ channel inactivation and an abnormal resting membrane potential, but it is not controls neurotransmitter release at most central synapses and at the neuromuscular junction (NMJ).
clear how this altered function produces the clinical phenotype. N-type VGCCs may also play a role in exocytosis at certain central synapses (Table 1) . 18 Malignant hyperthermia is an autosomal dominant disorder of skeletal muscle in which crises of hyperthermia, skeletal muscle rigidity, tachyarrythmia and acidosis may be triggered by volatile anaesthetics
The Lambert-Eaton myasthenic and depolarising muscle relaxants. Whilst in most syndrome (LEMS) cases it is caused by mutations in the ryanodine LEMS is a disorder characterized by skeletal muscle receptor (muscle sarcoplasmic reticular efflux Ca2+ weakness and autonomic dysfunction. In 60% of channel),26 it has also been described in association cases it is considered paraneoplastic and associated with mutations in the a 1S skeletal muscle with an underlying small-cell lung carcinoma. Most L-type VGCC on chromosome 1q31,27 and linkage evidence suggests that P/Q-type channels control has been established to 7q21-22 which encompasses acetylcholine release from motor nerve terminals at the CACNA2 gene for the a 2 d accessory subunit28 the NMJ19 and antibodies directed against P/Q-type ( Table 2) The gene encoding the human P/Q-type VGCC a 1A the ability of LEMS antisera to passively transfer the subunit has been identified on the long arm of disease to animals.4 These anti-VGCC antibodies are chromosome 19 and designated CACNA1A.29 Three thought to exert their effect by causing VGCC apparently distinct neurological disorders have been internalization and consequent reduction in the shown to be associated with different mutations in number of VGCCs available for coupling to neurothis gene ( 
on the VGCC involved in neurotransmitter release at The hereditary spinocerebellar ataxias are a genetically and neurologically heterogeneous group of the NMJ implicates the P/Q-type VGCC, but (rabbit) skeletal muscle L-type VGCC were used in the conditions characterized by dysfunction of the cerebellum and its afferent and efferent connections.
seminal study claiming the presence of anti-VGCC antibodies in patients with ALS.8 There is no ready Spinocerebellar ataxia type-6 (SCA6) has been shown to be caused by a modest expansion of a explanation for how antibodies directed against a skeletal muscle isoform of the VGCC may mediate polymorphic CAG repeat in the CACNA1A gene. This is translated into a polyglutamine repeat which a functional effect on the motor nerve. is located within the C-terminal intracytoplasmic tail of the P/Q-type VGCC.3
The Tottering, Leaner, Lethargic and Stargazer mice X-linked congenital stationary night
The epilepsies are a heterogeneous group of paroxysblindness mal disorders characterized by recurrent synchronized neuronal discharges. Many human epilepsy X-linked congenital stationary night blindness syndromes are likely to have an important genetic (xlCSNB) is a recessive non-progressive retinal discomponent, but efforts to identify these genetic order characterized by night blindness, decreased factors are complicated by clinical and genetic visual acuity, myopia, nystagmus and strabismus.
heterogeneity. In the mouse, a number of single gene This is a clinically and genetically heterogeneous mutations that cause epilepsy have been identified condition with at least two different loci identified.
and it is possible that investigation of these genes The disorder is thought to result from impaired will provide insights into the human epilepsies. synaptic transmission between photoreceptors and
The tottering mouse represents a recessive model second-order (bipolar) retinal neurons. A connection of absence epilepsy characterized by ethosuxamidewith calcium channels was first considered when it responsive behavioural arrest accompanied by a was established that L-type VGCCs were important generalized spike and wave discharge. In addition in the release of glutamate from photoreceptor preto absence seizures, the tottering mouse also synaptic terminals in the frog retina.31 More recently, develops motor seizures and ataxia. Point mutations a novel retinal-specific gene has been mapped to have been identified in the mouse a 1A gene in this Xp11.23 and characterized as an L-type VGCC a 1 -spontaneous mouse model of absence epilepsy and subunit (which has been designated CACNA1F).
ataxia.11 The leaner mouse model is characterized Analysis of a number of different pedigrees with by severe progressive ataxia and absence seizures. It xlCSNB has demonstrated 15 different mutations results from a mutation that causes a frame shift and which manifest as missense, nonsense, deletions or premature stop codon in the a 1A subunit of the frameshifts with or without a premature stop codon.6,7 VGCC.11 These mutations are summarized in Figure 2 and Homozygous lethargic mice express a phenotype Table 2 . It is predicted that these represent loss-ofcharacterized by lethargic behaviour and ataxia, as function mutations which would impair the influx of well as focal motor and absence seizures. A mutation calcium required for the tonic release of glutamate in the gene encoding the VGCC b 4 subunit (Cchb4) from photoreceptor presynaptic terminals in has recently been shown to be responsible for the darkness.6 lethargic mouse. The identified mutation comprises a four nucleotide insertion into a splice donor site which results in exon skipping, translational
Amyotrophic lateral sclerosis frameshift and protein truncation with loss of the a 1 -binding site.12 Whilst this mutation might be preIt has been suggested that anti-VGCC antibodies may be present in a large proportion of patients with ALS.8 dicted to produce a truncated b 4 protein that does not possess the a 1 -binding site, western analysis has Other investigators, however, have been unable to confirm these results.32 Furthermore, the data which demonstrated that there is complete loss of b 4 expression in both cerebellum and forebrain14 and favour a pathogenic role of these antibodies in ALS include a number of apparent contradictions. that this is accompanied by decreased expression of N-type VGCCs. Furthermore, there is increased fracAlthough it was initially shown that these antibodies enhance spontaneous neurotransmitter release from tional incorporation of the b 1b subunit into N-type VGCCs in the forebrain. This may alter N-type VGCC motor nerve terminals,33 this being taken to imply
There is now good evidence that the disease-causing sion on the assembly and function of other types of VGCCs has not yet been examined.
antibodies specifically target the a 1A P/Q-type VGCCs. In FHM, EA-2 and SCA-6, different types of Stargazer is a spontaneous mouse model of epilepsy characterized by absence seizures, a distinctive mutations in the a 1A gene (CACNA1A) have been shown to segregate with disease. However, there is, head movement presumed to be due to vestibular disturbance, and cerebellar dysfunction. The gene as yet, no functional data to demonstrate the precise nature of the functional abnormality of the VGCC defect underlying the stargazer mutant has recently been identified as the insertion of a long transposon which results in the particular disease phenotype. The demonstration that FHM, EA-2 and SCA-6 are into intron-1 of a gene designated Cacng2, which manifests as (incomplete) transcriptional terminaall allelic, and that they affect the same gene product which is the target of the immune response in LEMS, tion.10 Cacng2 has sequence and structural similarity to the skeletal muscle VGCC c-subunit, and is raises further questions. If dysfunction of the P/Qtype VGCC underlies all of these disorders, why do expressed exclusively in the brain, where it is enriched in the synaptic plasma membrane. Regional the autoantibodies in LEMS not produce migraine, ataxia or spinocerebellar degeneration? Could this expression is highest in the cerebellum, olfactory bulb, thalamus and hippocampus, similar to that of simply result from failure of the autoantibodies to cross the blood brain barrier? Similarly, why are the a 1A subunit, and the stargazer phenotype is similar to that of the tottering and lethargic mice none of the symptoms of LEMS present in patients with FHM, EA-2 or SCA-6? The answers to these which harbour defects in the a 1A and b 4 subunits of the VGCC, respectively. Coexpression of a 1A and the questions will hopefully follow from elucidation of the distinct functional abnormalities which result protein product of the wild-type Cacng2 gene (stargazin) in BHK cells leads to a shift in the voltagefrom the various mutations in CACNA1A.
The original descriptions of the genetics of EA-2 dependence of a 1A VGCC inactivation towards more negative potentials, significantly reducing channel and SCA-6 suggested that they were phenotypically and genetically distinct disorders. SCA-6, characteravailability at the neuronal resting membrane potential of −70 mV.10 This is consistent with the effect ized by permanent and progressive cerebellar atrophy and dysfunction, was found to be due to a small CAG of the skeletal muscle VGCC c-subunit on the function of the a 1S VGCC. Reduced expression of repeat expansion. EA-2 results from a truncated protein and manifests as mild and intermittent cerestargazin, as expected in the stargazer mouse, would result in increased or inappropriate Ca2+ entry into bellar dysfunction. More recently, however, it has been suggested that small CAG expansions in the the presynaptic terminal. Together, these data suggest that stargazin is a novel VGCC c-subunit.
CACNA1A gene may also be responsible for intermittent cerebellar deficit, and this has raised doubts The stargazer mutant, therefore, predicts an increase in presynaptic Ca2+ entry, whereas reduced about the distinction between SCA-6 and EA-2. 35 The elucidation of the molecular genetic basis Ca2+ entry is expected in the tottering mouse. How such apparently different effects may account for a for FHM, and the demonstration of linkage of common forms of migraine with and without aura similar phenotype is not well established, but may relate to the balance between the release of excitatory to the same locus in certain families, raises the intriguing possibility that abnormalities of the and inhibitory neurotransmitters or to the effects of downstream second-messenger systems. In this same VGCC may underly the more common forms of the disease. Enthusiasm for such prospects, howregard, it has been suggested that the effect of the stargazer mutation in reducing the expression of ever, should be tempered by the recognition that FHM is genetically heterogeneous, with two brain-derived neurotrophic factor (BDNF) in the cerebellar granular layer may be responsible for the further loci having been identified.36,37 Even greater genetic heterogeneity is apparent in the spinocerebelataxia manifest in this mouse.10 lar ataxias, with seven different loci established and further heterogeneity likely. These observations make it difficult to extrapolate from these rare Mendelian Discussion disorders to the more common complex traits of sporadic disease. Although VGCCs have now been implicated in a wide range of diseases, the details of our understand-
The observation that abnormalities of the VGCC complex underlie the absence epilepsy of the toting of the precise role that these channels play in disease, is very variable. It is well established tering, leaner, lethargic and stargazer mice raises the exciting prospect that similar dysfunction may that LEMS is an autoimmune disease, and that the antagonists are already well-established agents in the available for the in vitro investigation of some of the
